# Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above

> **NCT00476307** · PHASE3 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 120 (estimated)

## Conditions studied

- Influenza

## Interventions

- **BIOLOGICAL:** Fluarix™/Influsplit SSW® 2007/2008

## Key facts

- **NCT ID:** NCT00476307
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2007-06
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2016-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00476307

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00476307, "Immunogenicity and Reactogenicity of Fluarix™ (Influsplit SSW®) 2007/2008 in People 18 Years Old or Above". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT00476307. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*